United States - English - NLM (National Library of Medicine)

alternate pharmacy - american ginseng (unii: 8w75vcv53q) (american ginseng - unii:8w75vcv53q), avena sativa flowering top (unii: ma9cqj3f7f) (avena sativa flowering top - unii:ma9cqj3f7f), potassium phosphate, dibasic (unii: ci71s98n1z) (phosphate ion - unii:nk08v8k8hr), phosphoric acid (unii: e4ga8884nn) (phosphoric acid - unii:e4ga8884nn), picric acid (unii: a49os0f91s) (picric acid - unii:a49os0f91s), ginger (unii: c5529g5jpq) (ginger - unii:c5529g5jpq) - for temporary relief of weakness and lethargy. for temporary relief of weakness and lethargy.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

periplaneta americana) 0.5mg/ml solution for skin prick test (diater - american cockroach (periplaneta americana) allergen extract - solution for skin-prick test

Australia - English - Department of Health (Therapeutic Goods Administration)

stallergenes australia pty ltd - american house dust mite extract, quantity: 5 ir/ml; european house dust mite extract, quantity: 5 ir/ml - injection, suspension - excipient ingredients: sodium chloride; phenol; water for injections; aluminium hydroxide hydrate; mannitol - treatment of patients with type 1 allergy (gell and coombs classification), particularly presenting as seasonal or perennial rhinitis, conjunctivitis, rhinoconjunctivitis, with or without associated asthma.

Australia - English - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - european house dust mite extract, quantity: 6 sq-hdm; american house dust mite extract, quantity: 6 sq-hdm - tablet - excipient ingredients: gelatin; sodium hydroxide; purified water; mannitol - allergic rhinitis acarizax is indicated for the treatment of house dust mite (hdm) allergic rhinitis not well controlled despite use of symptom relieving medication in adults and adolescents (? 12 years). allergic asthma acarizax is indicated for the treatment of hdm allergic asthma not well controlled by inhaled corticosteroids and associated with hdm allergic rhinitis in adults. patients? asthma status should be carefully evaluated before the initiation of treatment.

Australia - English - Department of Health (Therapeutic Goods Administration)

stallergenes australia pty ltd - european house dust mite extract, quantity: 5 ir/ml; american house dust mite extract, quantity: 5 ir/ml - injection, suspension - excipient ingredients: aluminium hydroxide hydrate; phenol; sodium chloride; water for injections; mannitol - treatment of patients with type 1 allergy (gell and coombs classification), particularly presenting as seasonal or perennial rhinitis, conjunctivitis, rhinoconjunctivitis, with or without associated asthma.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

moh pharmaceutical technologies sdn. bhd. - american ginseng -

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

american) (ostrya virginiana) pollen 100dbu/ml solution for skin prick test (lofarma - hornbeam (american) (ostrya virginiana) pollen allergen extract - solution for skin-prick test

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

inmunotek - american cockroach (periplaneta americana) allergen extract - solution for skin-prick test

United States - English - NLM (National Library of Medicine)

antigen laboratories, inc. - periplaneta americana (unii: 2rq1l9n089) (periplaneta americana - unii:2rq1l9n089) - periplaneta americana 0.1 g in 1 ml - allergenic extract is used for diagnostic testing and for the treatment (immunotherapy) of patients whose histories indicate that upon natural exposure to the allergen, they experience allergic symptoms. confirmation is determined by skin testing. diagnostic use of allergenic extracts usually begins with direct skin testing. this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. do not administer in the presence of diseases characterized by bleeding diathesis. individuals with autoimmune disease may be at risk of exacerbating symptoms of the underlying disease, possibly due to routine immunization. patients who have experienced a recent myocardial infarction may not be tolerant of immunotherapy. children with nephrotic syndrome probably should not receive injections due to immunization causing exacerbation of nephrotic disease.

Australia - English - Department of Health (Therapeutic Goods Administration)

stallergenes australia pty ltd - american house dust mite extract, quantity: 10 ir/ml - injection, suspension - excipient ingredients: mannitol; aluminium hydroxide hydrate; sodium chloride; phenol; water for injections - treatment of patients with type 1 allergy (gell and coombs classification), particularly presenting as seasonal or perennial rhinitis, conjunctivitis, rhinoconjunctivitis, with or without associated asthma.